News

BrightFocus Foundation's new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.

A BrightFocus Alzheimer’s Disease Research-funded scientist is investigating how “jumping genes” may fuel brain inflammation in Alzheimer’s—and whether blocking them could prevent or slow dementia.

A National Glaucoma Research-funded scientist is pioneering the use of artificial intelligence and telemedicine to detect glaucoma earlier, improve access to care, and prevent irreversible blindness.

With funding from Macular Degeneration Research, Dr. Daisy Shu is exploring advanced drug delivery systems that release medicine slowly over time. This innovative approach could reduce the number of injections needed for macular degeneration while maintaining vision-saving results.

New formulation of Leqembi allows weekly at-home injections, reducing the need for hospital visits.

In this issue: Can Stem Cells Restore Vision Loss? Your Macula—How It Works and How to Protect It, Announcing $3.8 Million in Grants to Save Sight, and more!